Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary FibrosisTake-Home Poin... by Steven D. Nathan, MD, Juergen Behr, MD, Vincent Cottin, MD, Lisa Lancaster, MD, Peter Smith, PharmD, CQ Deng, PhD, Natalie Breytenbach, PharmD, Heidi Bell, MD, Leigh Peterson, PhD, Kevin R. Flaherty, MD

Get full text

Sustained Molecular Allograft Injury After Episodes of Acute Rejection and Organizing Pneumonia Increases the Risk of Lung Allograft Failure by Michael B. Keller, MD, Allison Y. Lin, Moon Kyoo Jang, PhD, Hyesik Kong, PhD, Ananth Charya, MD, Gerald J. Berry, MD, Charles C. Marboe, MD, Ileana L. Ponor, MD, MBA, Shambhu Aryal, MD, Jonathan B. Orens, MD, Pali D. Shah, MD, Steven D. Nathan, MD, Xin Tian, PhD, Sean Agbor-Enoh, MD, PhD

Get full text

Surfactant Protein D and Club Cell Secretory Protein as Biomarkers of Disease Severity and Fostamatinib Efficacy in Severe COVID-19 by Marcos J. Ramos-Benitez, PhD, Rui Miao, PhD, Andrea P. Rivera-Torres, MS, Mercedes Lacourt-Ventura, MS, Sonya J. Malavez-Cajigas, MS, Xin Tian, PhD, Heather L. Teague, PhD, Wilfredo De Jesus-Rojas, MD, Robert Reger, MS, Anthony F. Suffredini, MD, Christopher King, MD, Steven D. Nathan, MD, Richard W. Childs, MD, Jeffrey R. Strich, MD

Get full text